Atmogine 8 Tablet containing Atomoxetine is used for the management of attention deficit hyperactivity disorder (ADHD). It helps in improving attention span, reducing impulsivity, and enhancing behavioral control.
Atomoxetine works by selectively inhibiting the reuptake of norepinephrine in the brain, which helps regulate attention and behavior in patients with ADHD.
The tablet is widely prescribed in pediatric and psychiatric practice, leading to consistent demand and long-term usage in ADHD management.
With increasing awareness and diagnosis of behavioral disorders, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and growing acceptance make it a reliable product for consistent sales and growth in the neuro-psychiatric segment.
Some patients may experience decreased appetite, nausea, dry mouth, dizziness, or sleep disturbances. In some cases, mood changes, increased heart rate, or blood pressure fluctuations may occur. Rarely, serious effects such as suicidal thoughts or liver dysfunction may arise and require immediate medical attention.
Atmogine 8 Tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It helps improve concentration, reduce impulsive behavior, and control hyperactivity, thereby improving daily performance and quality of life.
This medicine should be used under strict medical supervision. Regular monitoring of heart rate, blood pressure, and behavioral changes is recommended. Use with caution in patients with cardiovascular or psychiatric conditions.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.